Long-acting intramuscular injectable form of paliperidone (Invega Sustenna) for schizophreniaLong-acting intramuscular injectable form of paliperidone (Invega Sustenna) for schizophrenia

Published 2011-12-01 00:00:00

A long-acting intramuscular injectable or depot form of paliperidone was listed on the Pharmaceutical Benefits Scheme (PBS) as Authority required (streamlined) on 1 December 2011*.1,2 It is an alternative to existing long-acting antipsychotics for people with schizophrenia. A maintenance dose is given once a month.3 Paliperidone is the main active metabolite of risperidone2: refer to the product information for information about switching people from oral paliperidone, or oral or injectable risperidone, to injectable paliperidone.3

*Paliperidone tablets have been PBS listed (Authority required [streamlined]) for schizophrenia since 1 April 2008.

References

  1. Pharmaceutical Benefits Advisory Committee. Paliperidone palmitate, aqueous suspension for injection, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg, pre-filled syringe (Invega Sustenna): public summary document. Canberra: Australian Government Department of Health and Ageing, 2011. http://www.health.gov.au/internet/main/publishing.nsf/Content/pbac-psd-paliperidone-nov10 (accessed 5 October 2011).
  2. National Prescribing Service. Paliperidone (Invega) for schizophrenia. NPS RADAR April 2008. Sydney: National Prescribing Service, 2008. http://www.nps.org.au/health_professionals/publications/nps_radar/2008/april_2008/paliperidone (accessed 5 October 2011).
  3. Janssen-Cilag Pty Ltd. Invega Sustenna product information. 14 March 2011. http://www.janssen.com.au/files/Products/Invega_Sustenna_PI.pdf (accessed 5 October 2011).
RSS FeedRSS feed

Date published: 2011-12-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.